Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure
Robel K Gebre(Mayo Clinic), Clifford R. Jack(Mayo Clinic), Alejandro Costoya‐Sánchez(Universidade de Santiago de Compostela), Anthony J. Spychalla(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic in Arizona), Melissa E. Murray(Jacksonville College), David S. Knopman(Mayo Clinic), Fiona Heeman(Amsterdam University Medical Centers), Michael Schöll(Wallenberg Wood Science Center), Jonathan Graff-Radford(Mayo Clinic), Christopher G. Schwarz(Mayo Clinic), Sheelakumari Raghavan(Mayo Clinic), Ronald Petersen(Mayo Clinic), Val J. Lowe(Mayo Clinic), Heather J. Wiste(Mayo Clinic in Florida)
Cited by 11
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k